ALTIMMUNE, INC. Operating Lease, Expense
ALTIMMUNE, INC. (ALT) reported Operating Lease, Expense of $600.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-03-06
- ALTIMMUNE, INC. operating lease, expense for the quarter ending 2024-12-31 was $100.00K, a 0.00% change year-over-year.
- ALTIMMUNE, INC. operating lease, expense for the quarter ending 2024-09-30 was $100.00K, a 0.00% change year-over-year.
- ALTIMMUNE, INC. operating lease, expense for the quarter ending 2024-06-30 was $100.00K, a 0.00% change year-over-year.
- ALTIMMUNE, INC. operating lease, expense for the quarter ending 2024-03-31 was $200.00K, a 0.00% change year-over-year.
- ALTIMMUNE, INC. operating lease, expense for fiscal 2025 was $600.00K, a 20.00% increase from fiscal 2024.
- ALTIMMUNE, INC. operating lease, expense for fiscal 2024 was $500.00K, a 0.00% change from fiscal 2023.
- ALTIMMUNE, INC. operating lease, expense for fiscal 2023 was $500.00K, a 0.00% change from fiscal 2022.
- ALTIMMUNE, INC. operating lease, expense for fiscal 2022 was $500.00K, a 0.00% change from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $600.00K 10-K · filed 2026-03-06 | |||
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $200.00K derived: sum of 2 quarters · filed 2026-03-06 | $300.00K derived: sum of 3 quarters · filed 2026-03-06 | $500.00K 10-K · filed 2026-03-06 |
| 2024-09-30 | $100.00K 10-Q · filed 2024-11-12 | $200.00K derived: sum of 2 quarters · filed 2024-11-12 | $400.00K 10-Q · filed 2024-11-12 | $500.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-06-30 | $100.00K 10-Q · filed 2024-08-08 | $300.00K 10-Q · filed 2024-08-08 | $400.00K derived: sum of 3 quarters · filed 2025-02-27 | $500.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-03-31 | $200.00K 10-Q · filed 2024-05-09 | $300.00K derived: sum of 2 quarters · filed 2025-02-27 | $400.00K derived: sum of 3 quarters · filed 2025-02-27 | $500.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $200.00K derived: sum of 2 quarters · filed 2025-02-27 | $300.00K derived: sum of 3 quarters · filed 2025-02-27 | $500.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-12 | $200.00K derived: sum of 2 quarters · filed 2024-11-12 | $400.00K 10-Q · filed 2024-11-12 | $500.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-08 | $300.00K 10-Q · filed 2024-08-08 | $400.00K derived: sum of 3 quarters · filed 2024-08-08 | $500.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $200.00K 10-Q · filed 2024-05-09 | $300.00K derived: sum of 2 quarters · filed 2024-05-09 | $400.00K derived: sum of 3 quarters · filed 2024-05-09 | $500.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $200.00K derived: sum of 2 quarters · filed 2024-03-27 | $300.00K derived: sum of 3 quarters · filed 2024-03-27 | $500.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-07 | $200.00K derived: sum of 2 quarters · filed 2023-11-07 | $400.00K 10-Q · filed 2023-11-07 | $400.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-10 | $200.00K 10-Q · filed 2023-08-10 | $300.00K derived: sum of 3 quarters · filed 2023-08-10 | $400.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-11 | $200.00K derived: sum of 2 quarters · filed 2023-05-11 | $300.00K derived: sum of 3 quarters · filed 2023-05-11 | $400.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $200.00K derived: sum of 2 quarters · filed 2023-02-28 | $300.00K derived: sum of 3 quarters · filed 2023-02-28 | $500.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-10 | $200.00K derived: sum of 2 quarters · filed 2022-11-10 | $400.00K 10-Q · filed 2022-11-10 | $400.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $100.00K 10-Q · filed 2022-08-11 | $300.00K 10-Q · filed 2022-08-11 | $300.00K derived: sum of 3 quarters · filed 2022-08-11 | $400.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-12 | $200.00K derived: sum of 2 quarters · filed 2022-05-12 | $300.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $200.00K derived: sum of 2 quarters · filed 2022-03-15 | $400.00K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $100.00K 10-Q · filed 2021-11-09 | $300.00K 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |